Vimarsana
Biggest News Aggregation in the World

Pfizer Jab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Jab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Jab Today - Breaking & Trending Today

The Centner Academy: Miami School Orders Students Who Got Vaccinated to Quarantine for 30 Days - Vimarsana News

The Centner Academy: Miami School Orders Students Who Got Vaccinated to Quarantine for 30 Days

The Centner Academy is a private school in Miami with at least 300 students, and its officials have also barred its teachers from getting the COVID-19 vaccine.

न्यूरोलॉजिकल समस्या वाले बच्चों के लिए क्‍यों प्रभावी है Pfizer वैक्सीन, क्‍या कहती है यह स्टडी - Vimarsana News

न्यूरोलॉजिकल समस्या वाले बच्चों के लिए क्‍यों प्रभावी है Pfizer वैक्सीन, क्‍या कहती है यह स्टडी

स्टडी से ये पता चला है कि इस वैक्सीन को लेने के बाद बच्चों में अच्छी मात्रा में एंटीबॉडी बनी है और ये काफी प्रभावी भी है। इसके साथ ही जिन बच्चों की पहले से कोई भी स्वास्थ्य संबंधी परेशानी है उनमें भी यह वैक्सीन बहुत कारगर है।

Pfizer jab side effects in 12-15yr olds at high risk of COVID-19 complications: Study - Vimarsana News

Pfizer jab side effects in 12-15yr olds at high risk of COVID-19 complications: Study

The findings of the study were published in the journal 'Archives of Disease in Childhood'

Pfizer jab produces less antibodies against Delta variant of coronavirus: Lancet study - Vimarsana News

Pfizer jab produces less antibodies against Delta variant of coronavirus: Lancet study

The researchers noted that the most important thing is to ensure that vaccine protection remains high enough to keep as many people out of hospital as possible.

Pfizer jab produces less antibodies against Delta variant: Lancet - Vimarsana News

Pfizer jab produces less antibodies against Delta variant: Lancet

Read more about Pfizer jab produces less antibodies against Delta variant: Lancet on Business Standard. People fully vaccinated with two doses of the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant